[Edaily Starin KIM HYUNSIK Reporter] Singer Tiffany Young will release her first solo studio album, "Edge of Calm," on the 20th. (Photo courtesy of Pacific Music Group)Tiffany Young debuted as a member of the group Girls’ Generation in 2007 and has been pursuing a solo career alongside her group activities since 2016. As this marks her first full-length album release, fans’ expectations are high. The album features a total of 11 tracks, including the double title tracks “Edge of Calm” and “Lips Together,” as well as “Codes,” “Drip Drop,” “Halfway Honest,” “Moment,” “Lovers,” “Summer’s Not Over,” and “Moonlit Rain.” Of the two title tracks, “Edge of Calm” is a song about the moment of quietly embracing a partner caught in a whirlwind of anxiety and emotions, standing by their side in silence. “Lips Together” is a song expressing the desire to have a wounded heart healed by love, featuring Miyeon from the group A.I.D. as a guest artist. Her agency, Pacific Music Group, explained, “We structured the album around songs that explore the moments where subtle tension just before stillness, concentration, and emotional balance intersect.” They added, “With this album, Tiffany Young will showcase a new direction and an expanded musical universe.” Tiffany Young was directly involved in the album’s concept planning, styling, visual direction, and music video storytelling, and she also contributed to the lyrics for the track “Moonlin Late.” All tracks from the album will be released at 6:00 p.m. today via various online music platforms.
(Photo: Blind)
One of the concerns facing the Lee Jae-myung administration is the decline in support among young people. According to Gallup Korea’s presidential job approval ratings, the approval…
The KRX Health Care Index rose 4.53% from the previous session on Oct. 1, signaling a rare tailwind for South Korea’s pharmaceutical and biotech sector. Among the gainers, GIInnovation and G2GBio drew…
(Graphic: ChatGPT)
“While existing ex vivo chimeric antigen receptor T-cell (CAR-T) therapies are personalized treatments that require cell collection from each patient for manufacturing, the in v…